A Cure No More? Proposed Alzheimer’s Drug Is Virtually Not Effective, Researchers Say
In its quest to fight Alzheimer's, pharmaceutical giant Merck has recently announced that halting of their late-stage trial of its promising Alzheimer's drug, verubecestat. The decision was said to have come after after an independent study has determined that there was virtually no chance of it working. Prior to this, it was found that solanezumab, another Alzheimer's drug has also been identified as a failure after patients taking it demonstrated no signs of improvement compared to those taking a placebo.
Merck's Failure To Launch Alzheimer's Drug
In one of his statements reported by Local SYR, president of Merck Research Laboratories, Dr. Roger Perlmutter said that despite the fact that they are disappointed with the results that a benefit was not observed in this study, he reveals that their work continues to study the impact of verubecestat in people with less advanced disease. It was found that both of Merck's drugs target the beta amyloid plaque, which is the sticky gunk that accumulates in the brains of people with the disease. Apparently, a significant number of experts say that the failure of the drug on people with mild-to-moderate Alzheimer's can be considered as a substantial setback.
Furthermore, according to reports by New Scientist, authorities have revealed that Merck's drug, which has been tested on people with mild or moderate Alzheimer's, did not help them at all, despite earlier studies showing that it could safely switch off the production of amyloid in the brain. Bryce Vissel, from the University of Technology Sydney in Australia has also said that numerous attempts by many drug companies to block amyloid in the brain have failed, repeatedly, which have led him to advocate to new approaches that needs to be developed, and new directions in research supported. As of the press time, the Alzheimer's Disease International said that around 47 million people currently live with dementia worldwide, with Alzheimer's estimated to account for 60 to 80% of dementia cases.
A Cure No More?
Meanwhile, despite Merck's failure, authorities say that it may not be the end of the verubecestat story, because a parallel study of the drug continues. It might not have worked in people with mild or moderate Alzheimer's because there was already too much amyloid plaque in the brain. Researchers have further revealed that the parallel study is allegedly looking into the drug's effect in people at a much earlier stage of the disease, when patients are believed to have so little plaque that's stopping it in its tracks will prevent further symptoms.
Vitamin D Finally Sheds Light To Answering A Number Of Winter Infections
Considering the prevalence of a number of winter infections such as colds and flu, what’s the truth behind claims that Vitamin D intake could have the ability of stopping these illnesses from ever taking place? Have we just found ourselves the right protection from these diseases? Find out what experts have to say
BPaMZ And BPaL: These Two New Drug Therapies Might Cure All Forms Of Tuberculosis
Considering the adverse impacts brought by tuberculosis, is there still hope for the infectious bacterial disease? With the discovery of these two new drug therapies, what’s the truth behind claims that the answer for tuberculosis has finally arrived? Find out what health professionals have to say
Health Alert: Belly Fat May Lead To Heart Disease And More, Study Finds
Belly fat is probably one of the most common types of belly that everybody has seen before. More than just being fat tummy, what’s the truth behind these new claims that a belly fat may trigger heart disease and even diabetes? How is that even possible to happen? Here’s what health professionals have to say
Excessive Sleep Is a Sign of Dementia; Here Are Other Symptoms
Excessive sleep is a symptom of dementia, but not the cause of dementia, researchers have found. The new study also found that people who sleep for over 9 hours every day increase their risks of developing dementia two fold within 10 years. And then, MRI scans of the brain reveal that people who sleep in excess of 9 hours daily have smaller brain volumes compared with those who sleep less.
Brain Protein Regulation Aided By Cholesterol
Cholesterol can have effects even in the brain. Brain protein regulation is aided by cholesterol, as a study shows.
MORE IN ITECHPOST
The Role of Technology in Education in 2019
2019 is proving to be another great year for trends in educational technology. There are many upcoming trends that seem to have a bearing on the future of the sector with respect to technology.
New Retroreflective Material Could be Used in Nighttime Color-Changing Road Signs
BUFFALO, N.Y. -- A thin film that reflects light in intriguing ways could be used to make road signs that shine brightly and change color at night, according to a study that will be published on Aug. 9 in Science Advances.
Top 5 Video Games to Play for a Truly Unique First Date
Video games have a way of taking us outside of ourselves and live in a fantasy world. It's even better when you're playing a game with someone special!